ZA92661B - Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis - Google Patents

Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis

Info

Publication number
ZA92661B
ZA92661B ZA92661A ZA92661A ZA92661B ZA 92661 B ZA92661 B ZA 92661B ZA 92661 A ZA92661 A ZA 92661A ZA 92661 A ZA92661 A ZA 92661A ZA 92661 B ZA92661 B ZA 92661B
Authority
ZA
South Africa
Prior art keywords
prevention
treatment
pharmaceutical combination
postmenopausal osteoporosis
postmenopausal
Prior art date
Application number
ZA92661A
Inventor
Paolo Chiesi
Chiesi Paolo
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ZA92661B publication Critical patent/ZA92661B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
ZA92661A 1991-02-01 1992-01-30 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis ZA92661B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910253A IT1244697B (en) 1991-02-01 1991-02-01 PHARMACEUTICAL ASSOCIATION FOR THE PREVENTION AND TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS

Publications (1)

Publication Number Publication Date
ZA92661B true ZA92661B (en) 1992-10-28

Family

ID=11358374

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92661A ZA92661B (en) 1991-02-01 1992-01-30 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis

Country Status (9)

Country Link
EP (1) EP0569415A1 (en)
AU (1) AU1188492A (en)
CA (1) CA2101547A1 (en)
HU (1) HUT64848A (en)
IE (1) IE920219A1 (en)
IT (1) IT1244697B (en)
NZ (1) NZ241418A (en)
WO (1) WO1992013538A1 (en)
ZA (1) ZA92661B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023716A1 (en) * 1993-04-16 1994-10-27 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US6319914B1 (en) 1993-11-05 2001-11-20 Apollo Biopharmaceuticals, Inc. Cytoprotective effect of polycyclic phenolic compounds
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US6326365B1 (en) 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
US6339078B1 (en) 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
JP2004524354A (en) * 2001-03-16 2004-08-12 ワイス Estrogen replacement therapy
WO2008051586A2 (en) 2006-10-24 2008-05-02 Krempin David W Anti-resorptive and bone building dietary supplements and methods of use

Also Published As

Publication number Publication date
ITMI910253A0 (en) 1991-02-01
IT1244697B (en) 1994-08-08
HUT64848A (en) 1994-03-28
WO1992013538A1 (en) 1992-08-20
AU1188492A (en) 1992-09-07
ITMI910253A1 (en) 1992-08-01
NZ241418A (en) 1993-03-26
HU9302183D0 (en) 1993-10-28
EP0569415A1 (en) 1993-11-18
CA2101547A1 (en) 1992-08-02
IE920219A1 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
IL102777A0 (en) Pharmaceutical combination formulation
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
IL104108A0 (en) Use of biphosphonates and parathyroid hormone for the treatment of osteoporosis
PL297747A1 (en) Prolonged action pharmaceutical dosage forms
EP0533471A3 (en) Treatment of contaminated substances
ZA931778B (en) Method and composition for the treatment of osteoporosis
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
GB9808936D0 (en) Combination therapy for the prevention and treatment of osteoporosis
GB9114950D0 (en) Pharmaceutical formulation
ZA92661B (en) Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
EP0676951A4 (en) Use of vitamin d glycosides for the treatment or prevention of osteoporosis.
GB9102727D0 (en) Pharmaceutical agent
IL108197A0 (en) Pharmaceutical composition for preventing or treating arterioscleriosis
ZA928198B (en) Substituted azaspiranes for use in the treatment of hyperlipidemia
GB9216061D0 (en) Pharmaceutical combination formulation
EP0653208A3 (en) Pharmaceutical agents for treatment or prevention of sunburn.
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
GB9216102D0 (en) Pharmaceutical substances
ZA925931B (en) Medicinal treatment
IL102796A0 (en) Medicinal treatment
GB9123572D0 (en) Pharmaceutical compositions and methods for the treatment of malignancy
IL101412A0 (en) Pharmaceutical dosage form
IL105105A0 (en) Pharmaceutical dosage form
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis